Skip to content
value.today

Innate Pharma SA vs Moderna, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Moderna, Inc. is the larger company by market value: $90.1 B against $230 M for Innate Pharma SA, 392 times as much (market caps of Jan 5, 2024 for Innate Pharma SA and Oct 30, 2026 for Moderna, Inc.). Innate Pharma SA's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
  • Moderna, Inc. had more revenue: $1.9 B against $10 M for Innate Pharma SA, both in the year to December 2025.
  • Both made a net loss: $55 M for Innate Pharma SA and $2.8 B for Moderna, Inc.
  • Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -545.9% for Innate Pharma SA.
  • Moderna, Inc. employs more people: 4,700 against 181 at Innate Pharma SA. Each employee brings in about $56,133 of revenue at Innate Pharma SA and $413,617 at Moderna, Inc.
  • Moderna, Inc.'s revenue grew faster in its latest fiscal year: -39.9% against -53.3% for Innate Pharma SA.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0342685102713702020202120222023202420252026Innate Pharma SA 38Moderna, Inc. 1370

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$5B$10B$14B$19B201720182019202020212022202320242025Innate Pharma SA $0BModerna, Inc. $2B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureInnate Pharma SA
IPHYF
Moderna, Inc.
MRNA · #275 in the world
Profile
Country🇫🇷 France🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded—2010
Size
Market cap$230 M*$90.1 B
Revenue$10 M$1.9 B
Net income$-55 M▲ best$-2.8 B
Employees1814,700
Valuation
Price to sales—35.7×
Price to book—10.4×
Free cash flow yield—-2.3%
Profitability
Gross margin—55.4%
Operating margin-599.5%-158.1%▲ best
Net margin-545.9%-145.2%▲ best
Return on equity—-28.9%
Growth
Revenue growth-53.3%-39.9%▲ best
Revenue growth, 3 years a year-44.9%▲ best-53.4%
Financial strength
Debt to equity—0.1×
Cash
Free cash flow margin-587.2%-106.2%▲ best
Shareholder returns
Shareholder yield—0.0%
Strength scores
Piotroski F-score—3 of 9
Altman Z-score zone—safe
Data as ofMarket cap Jan 2024; ratios FY2025Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Innate Pharma SA or Moderna, Inc.?

Moderna, Inc. is the larger company by market value: $90.1 B against $230 M for Innate Pharma SA, 392 times as much (market caps of Jan 5, 2024 for Innate Pharma SA and Oct 30, 2026 for Moderna, Inc.). Innate Pharma SA's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.

Which makes more money, Innate Pharma SA or Moderna, Inc.?

Moderna, Inc. had more revenue: $1.9 B against $10 M for Innate Pharma SA, both in the year to December 2025. Both made a net loss: $55 M for Innate Pharma SA and $2.8 B for Moderna, Inc.

Which is more profitable, Innate Pharma SA or Moderna, Inc.?

Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -545.9% for Innate Pharma SA.

Which has more employees, Innate Pharma SA or Moderna, Inc.?

Moderna, Inc. employs more people: 4,700 against 181 at Innate Pharma SA. Each employee brings in about $56,133 of revenue at Innate Pharma SA and $413,617 at Moderna, Inc.

Which is growing faster, Innate Pharma SA or Moderna, Inc.?

Moderna, Inc.'s revenue grew faster in its latest fiscal year: -39.9% against -53.3% for Innate Pharma SA.